Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Microwave Ablation Combined With Simultaneous TACE Plus Sintilimab for Unresectable HCC.

NCT04220944 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT04220944
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04220944 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Microwave Ablation Combined With Simultaneous TACE Plus Sintilimab for Unresectable HCC.
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 1
Overall status
Unknown status
Start date
January 1, 2020
Completion date
December 30, 2024
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic carcinoma